News

| Nir Knoll
December 31st, 2017

Gornitzky represents Priority Software in its acquisition of Acclivity LLC.

Gornitzky represented Priority Software in its acquisition of Acclivity LLC, a U.S. based ERP software developer for small and mid-size companies worldwide, and its affiliated LLCs.

Priority is a portfolio company of Fortissimo Capital, a prominent Israeli private equity fund and this is its fourth acquisition in recent months represented by our firm.

Priority was represented by Chaim Friedland (Partner), Sagit Amit Evan (Senior Associate), Nir Knoll (Associate).

August 28th, 2017

Gornitzky represents the underwriters, led by Oppenheimer & Co., in Intec Pharma’s offering.

Gornitzky represented the underwriters, led by Oppenheimer & Co., in the USD 57.5 million follow-on offering of Intec Pharma Ltd. on the NASDAQ Capital Market. Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology.

 

Oppenheimer & Co. Inc. acted as sole book-running manager for the offering. Roth Capital Partners acted as lead manager, and Maxim Group LLC acted as co-manager for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner), Danielle Skald (Associate) and Nir Knoll (Associate).

December 12th, 2016

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 86 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market

Gornitzky represented the underwriters, led by Jefferies and Cowen and Company, in the USD 86 million follow-on offering of NeuroDerm Ltd. on the NASDAQ Global Market. NeuroDerm Ltd. is a clinical stage pharmaceutical company developing treatments for central nervous system (CNS) disorders.

Jefferies and Cowen and Company acted as joint book-running managers for the offering. Raymond James & Associates and Roth Capital Partners acted as co-managers for the offering.

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Nir Knoll.

September 16th, 2015

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Fishman Thermo Technologies LTD. Fishman is a leading manufacturer and supplier of cooling system products for the automotive industry.

Gornitzky & Co. represented Fortissimo Capital Fund in its acquisition of Fishman Thermo Technologies LTD from Tene for Investment F.E., Limited Partnership, Origo 1 Manof Fund, Limited Partnership, Origo 2 Manof Fund, Limited Partnership & Ilanit Cohen. Fishman is a leading manufacturer and supplier of cooling system products for the automotive industry.

Fortissimo Capital Fund was represented by Chaim Friedland (Partner, Corporate/M&A), Avner Finkelshtein (Partner, Antitrust), Yehonatan RafAvi Meer, Nir Knoll and Noa Schweitzer

November 13th, 2017

Gornitzky represents underwriters in RedHill Biopharma’s USD 22.5 million public offering.

Gornitzky represented the underwriters, led by Cantor Fitzgerald and Nomura Securities, in RedHill Biopharma’s USD 22.5 million underwritten public offering of American Depositary Shares (ADSs) on the NASDAQ Capital Market. RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer, is dually traded on the NASDAQ and the Tel Aviv Stock Exchange (NASDAQ: RDHL, TASE: RDHL).

 

Cantor Fitzgerald and Nomura Securities acted as joint book-running managers for the offering. SMBC Nikko Securities acted as lead manager and H.C. Wainwright and Roth Capital acted as co-managers for the offering.

 

The underwriters were represented by Chaim Friedland (Partner), Ari Fried (Partner) and Nir Knoll (Associate).

August 13th, 2017

Gornitzky represents Fortissimo Capital Fund in its acquisition of Tuttnauer Co. Ltd. 

Gornitzky represented Fortissimo Capital Fund in its acquisition of Tuttnauer Co. Ltd. Since 1925, Tuttnauer has been and continues to operate as a leading manufacturer and supplier of autoclaves, washers and other sterilization applications and devices.

 

Fortissimo was represented by Chaim Friedland (Partner, Corporate/M&A), Idan Baki (Partner, Finance), Avner Finkelshtein (Partner, Antitrust), together with associates Yoav Meer, Alon Peled, Nir Knoll and Coral Leshez.

April 11th, 2016

Gornitzky & Co. is representing AHAVA shareholders in connection with the sale of 100% of AHAVA's shares to Fosun Group for an aggregate price of NIS 290 million

Gornitzky represented the shareholders of AHAVA - Dead Sea Laboratories Ltd., a manufacturer of cosmetic products composed of mineral-rich mud from the Dead Sea. Its products are sold in over 25 different countries. Gornitzky advised the shareholders in connection with the sale of 100% of the shares to the large Chinese investment conglomerate, Fosun Group, for an aggregate price of NIS 290 million. Within the framework of the agreement, Fosun will purchase the share capital of all of AHAVA’s shareholders, Gaon Holdings, the Livnat family, Shamrock Israel Growth Fund, Kibbutz Mitzpeh Shalem and Kibbutz Kalia.

 

See related article in Globes, one of Israel’s leading financial daily newspapers.

 

The shareholders were represented by Chaim Friedland (Partner, Corporate/M&A), Yoav Meer  (Corporate), Nir Knoll (Corporate), Danielle Skald (Tax), Bar Sarafian (Employment)